PAF Co-Pay Relief: COVID-19 & Post COVID Conditions

Funded

About

The PAF Co-Pay Relief: COVID-19 & Post COVID Conditions program offers essential financial support for patients using medications like Actemra, Olumiant, Veklury, Tofidence, Paxlovid, and Avtozma. Through this program, patients can receive assistance for co-pays, co-insurance, and medical insurance premiums. PAF Co-Pay Relief ensures timely financial relief for eligible individuals, helping them manage the costs associated with chronic illness treatments in the United States.

Insurance requirements: Commercially insured, Medicare / Medicaid

Enrollment Forms

Enrollment Form

Benefits

•$2300 annual maximum benefit

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: Yes

•Activation Required: No

Program Details

•Fund type: CoPay, Coinsurance & Deductible (medications and office visits), Over the Counter Medications, Medical Insurance Premiums

•Specific drug coverage is not indicated on program website; drug coverage must be verified by calling program at 18665123861

•Patients may complete the application online or by phone; once approved, patients will begin receiving funding immediately

•All patients approved for assistance are required to have their diagnosis and treatment verified by a member of the patient’s care team within 30 days of approval

•The CoPay Relief Program will confirm the patient's reported income to ensure that it is within the income eligibility guidelines for the program through an income verification screening process

•Once the application and attestation forms are completed, applicants will be notified of their eligibility for assistance immediately upon application to the program

Enrollment Forms

Enrollment Form